Dustin brings over fifteen years of experience and expertise in regenerative medicine to Virscio. Dustin has a broad background in proof of concept and IND-enabling, pre-clinical study design across multiple disease and asset classes. At Virscio, Dustin is responsible for working with sponsors to define alignment of development needs with our translational capabilities. Dustin additionally coordinates R&D collaborations with industry, academic and philanthropic partners and federal funding agencies to drive new model development, and strategic platform engagement. Dustin further advances platform application as a business development lead for external client relations. Prior to joining Virscio, Dustin was an Assistant Professor at Rush University Medical Center where he co-developed dopamine neuron cell products for Parkinson’s disease, advancing programs toward IND with two companies. Dr. Wakeman received his B.S. in Biology from the University of Illinois at Urbana-Champaign and Ph.D. in Biomedical Sciences from the University of California at San Diego.